The death of a five-month-old baby girl following heart surgery at a major hospital in eastern China has ignited nationwide outrage, raised serious questions about medical misconduct, and intensified long-standing public distrust of the country’s healthcare institutions.
The infant, often called “Xiaoluoxi” (小洛熙) — meaning “little Luoxi” — by the public, died in November 2024 after undergoing surgery for what doctors described as a congenital heart defect at Ningbo University Affiliated Women and Children’s Hospital. In the weeks that followed, her parents began a public campaign seeking answers. The controversy escalated sharply in December, when an autopsy report contradicted the hospital’s original diagnosis and surgical justification.
Autopsy findings contradict hospital diagnosis
On December 19, Luoxi’s mother released the autopsy report online. The report concluded that the child’s heart defect was a 3-millimeter secundum atrial septal defect, a common and mild condition that typically resolves on its own without surgery. Pediatric cardiac specialists cited by the family said that more than 80 percent of such defects heal naturally within a year, and asymptomatic patients generally never require surgical intervention.
Crucially, the autopsy found no evidence of the complex heart abnormalities previously cited by the hospital, including “coronary sinus–type atrial septal defect” or “unroofed coronary sinus syndrome.” The findings prompted widespread accusations that doctors had fabricated or exaggerated the diagnosis to justify surgery.
In an emotional statement, Luoxi’s mother wrote that she was “devastated beyond words” after reading the report, adding that medical professionals later told her the child “would have lived a normal life without surgery.”
For the best of our weekly content！
You are now signed up for our newsletter
Check your email to complete sign up
The autopsy also raised alarming questions about the surgical procedure itself. According to the report, a 6.5-centimeter intercostal incision and a 5-centimeter pericardial incision were not sutured internally, with only the skin closed. Investigators found 30 milliliters of blood pooled in the infant’s right chest cavity—roughly one-third of a baby’s total blood volume—as well as blood-tinged fluid remaining in the trachea.
Despite surgical records stating that “all patches were removed,” the autopsy found a 1.4 × 0.5 centimeter pericardial patch still inside the heart.
“These records were openly falsified,” Luoxi’s father said in a separate post. “What in the entire medical file can still be trusted?”
Official response leaves unanswered questions; parents face retallation for speaking out
On December 15, the Ningbo Municipal Health Commission issued a brief statement acknowledging that there had been “faults in the surgical assessment process.” The commission said the lead surgeon had been removed from his post and suspended from practice, but did not name him or address questions about his professional qualifications, the lack of operating-room surveillance footage, or potential systemic failures.
The autopsy itself was conducted on November 26, commissioned by the health authority with the consent of both the hospital and the family. However, the report was not released until nearly a month later, with no official explanation for the delay.
On February 18, the 35th day since their daughter’s death and a significant mourning day in Chinese tradition, Luoxi’s parents spoke publicly again, describing the personal toll of their pursuit of accountability.
The father said he lost his job in late November after beginning to seek redress for the alleged malpractice. The mother was later forced to resign. With their income cut off, the family sold their car to finance legal and investigative efforts. They say their social media accounts have been repeatedly restricted, posts removed, livestreams taken down, and even the child’s name intermittently censored online.
Despite mounting financial pressure, the parents have consistently refused public donations. “We are not seeking compensation,” the father said. “We only want the truth.”
Public distrust mounts
As the case gained attention, individuals claiming to be medical insiders began sharing detailed analyses online. One physician wrote that a defect of Luoxi’s size would not have warranted surgery under standard clinical practice, saying such cases are routinely monitored without intervention.
Others questioned the lead surgeon’s credentials, noting that he reportedly held only an undergraduate degree and was originally trained in pediatrics rather than cardiothoracic surgery. Commentators questioned how he was authorized to perform Level-4 high-risk cardiac surgery, the most complex classification.
Several medical professionals argued that the hospital should publicly release documentation showing the surgeon’s training, case history, risk authorization, and competency evaluations. Without such evidence, they said, the issue may point to institutional violations, not merely individual error.
More explosive allegations came from individuals claiming internal knowledge of the hospital. According to these accounts, the surgeon was pursuing academic promotion and research credentials, focusing on cardiac surgery in premature infants.
They alleged that after successfully operating on an extremely premature infant under expert supervision in Shanghai, the doctor sought to perform similar procedures independently. Luoxi — born prematurely and weighing just 1.5 kilograms at birth (about 3.3 pounds) — was allegedly selected as the next case, despite not medically requiring surgery.
The hospital has not responded to these claims.
The case has resonated deeply with the Chinese public, tapping into widespread skepticism toward medical institutions. In recent years, public trust has been eroded by reports of over-treatment, profit-driven care, falsified records, and opaque accountability
“This is not a medical accident,” one widely shared comment read. “A healthy child was operated to death.”